AlphaQuest’s Applied Therapeutics APLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,661
Closed -$466 143
2025
Q4
$466 Hold
4,661
﹤0.01% 2219
2025
Q3
$2.82K Hold
4,661
﹤0.01% 2201
2025
Q2
$1.45K Hold
4,661
﹤0.01% 1927
2025
Q1
$2.28K Buy
4,661
+1,806
+63% +$1.06K ﹤0.01% 1899
2024
Q4
$2.44K Buy
+2,855
New +$17.9K ﹤0.01% 1602

AlphaQuest's APLT Position: Q1 2026 in Review

AlphaQuest sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 4,661 shares — an estimated $466 sold.

AlphaQuest first reported a position in APLT in Q4 2024 and held it in 5 quarters. The position peaked at $2.82K in Q3 2025. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

  • AlphaQuest reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 4,661 Applied Therapeutics shares in Q1 2026, an estimated $466.
  • AlphaQuest first reported a position in Applied Therapeutics in Q4 2024 and held it in 5 quarters.
  • AlphaQuest's Applied Therapeutics position peaked at $2.82K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.